Vertex KALYDECO
Date:
Wednesday, February 1, 2012
The ECFS welcomes the approval of Vertex’s KALYDECO (ivacaftor) by the FDA.
Press release available here [1](external site)
Update from May 25, 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis. Further information in the Press Release here [2].